DAL vs STRO
Delta Air Lines Inc (DAL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the DAL and STRO stock pages for the full models.
Not investment advice.